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ABSTRACT
OBJECTIVES The aim of this study was to evaluate the combined impact of race, ethnicity, and sex on in-hospital
outcomes using data from the National Inpatient Sample.
BACKGROUND Cardiogenic shock (CS) is a major cause of mortality following ST-segment elevation myocardial
infarction (STEMI). Early revascularization reduces mortality in such patients. Mechanical circulatory support (MCS) de-
vices are increasingly used to hemodynamically support patients during revascularization. Little is known about racial,
ethnic, and sex disparities in patients with STEMI and CS.
METHODS The National Inpatient Sample was queried from January 2006 to September 2015 for hospitalizations with
STEMI and CS. The associations between sex, race, ethnicity, and outcomes were examined using complex-samples
multivariate logistic or generalized linear model regressions.
RESULTS Of 159,339 patients with STEMI and CS, 57,839 (36.3%) were women. In-hospital mortality was higher for all
women (range 40% to 45.4%) compared with men (range 30.4% to 34.7%). Women (adjusted odds ratio [aOR]: 1.11;
95% confidence interval [CI]: 1.06 to 1.16; p < 0.001) as well as Black (aOR: 1.18; 95% CI: 1.04 to 1.34; p ¼ 0.011) and
Hispanic (aOR: 1.19; 95% CI: 1.06 to 1.33; p ¼ 0.003) men had higher odds of in-hospital mortality compared with White
men, with Hispanic women having the highest odds of in-hospital mortality (aOR: 1.46; 95% CI: 1.26 to 1.70; p < 0.001).
Women were older (age: 69.8 years vs. 63.2 years), had more comorbidities, and underwent fewer invasive cardiac
procedures, including revascularization, right heart catheterization, and MCS.
CONCLUSIONS There are significant racial, ethnic, and sex differences in procedural utilization and clinical outcomes in
patients with STEMI and CS. Women are less likely to undergo invasive cardiac procedures, including revascularization
and MCS. Women as well as Black and Hispanic patients have a higher likelihood of death compared with White men.
(J Am Coll Cardiol Intv 2021;14:653–60) © 2021 by the American College of Cardiology Foundation.
C ardiogenic shock (CS) is a major cause ofmortality in patients with acute ST-segment elevation myocardial infarction
(STEMI) (1). Early mechanical revascularization im-
proves outcomes in such patients (2). Recent studies
have demonstrated that the use of shock protocols
may further improve outcomes (3–7). These protocols
incorporate key best practices, including early recog-
nition of CS and rapid delivery of invasive therapies,
including mechanical circulatory support devices,
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percutaneous coronary intervention (PCI),
and pulmonary artery catheterization.
Further study is necessary to prove the
efficacy of this approach through robust ran-
domized control trials. Given the heterogene-
ity of care present among patients with
STEMI and CS and the difficulties in recruit-
ing patients into such trials, it is likely that
shock protocols will continue to be increas-
ingly used across health systems (8–13).
It is unclear whether invasive revasculari-
zation procedures and mechanical hemody-
namic support devices are less frequently
used in women and racial and ethnic minor-
ities presenting with STEMI and CS. The
heterogeneity of care among patients with CS
may allow these sex, racial, and ethnic dis-
parities to go unnoticed. Studies have
demonstrated that women with STEMI are
less likely to receive invasive therapies
(8–10). Studies have also demonstrated that racial and
ethnic minorities with STEMI are less likely to receive
invasive therapies (11,12). We therefore sought to
evaluate the procedural and clinical outcomes of pa-
tients with STEMI and CS, on the basis of racial,
ethnic, and sex differences, in a large national
database.
METHODS
DATA SOURCE. The study was exempt from Insti-
tutional Review Board approval, as it was per-
formed using an anonymous dataset and because of
the deidentified nature of the publicly available
data in the National Inpatient Sample (NIS) data-
base. The NIS database is a publicly available
database of all-payer hospital inpatient stays
developed by the Agency for Healthcare Research
and Quality as part of the Healthcare Cost and
Utilization Project. We queried the NIS database
from January 2006 to September 2015. The NIS was
constructed from 22 states with reliable and verified
patient linkage numbers in the state inpatient da-
tabases that could be used to track patients across
hospitals within a state, while adhering to strict
privacy guidelines.
The NIS database includes approximately 14
million patients and about 2,000 hospitals per year.
National estimates are obtained using sampling
weights provided. A detailed explanation of all the
variables in the NIS is available online (https://www.
hcup-us.ahrq.gov/db/nation/nis/nisdde.jsp).
STUDY COHORT. The study population was identified
using the International Classification of Diseases-9th
Revision-Clinical Modification principal diagnostic
codes for STEMI (410.0x, 410.1x, 410.2x, 410.3x,
410.4x, 410.5x, 410.6x, and 410.8x) and a secondary
diagnosis of CS (785.51). Sex and race, and ethnicity,
cohorts were identified using the NIS variables “fe-
male” and “race” and ethnicity. “Black” refers to non-
Hispanic Black patients, “Hispanic” refers to Hispanic
patients of all races and origins, and “White” refers to
non-Hispanic White patients.
PATIENT AND HOSPITAL CHARACTERISTICS.
Baseline patient characteristics such as age, relevant
comorbidities, insurance, and median household in-
come were collected. The severity of comorbid con-
ditions was defined using a validated Deyo
modification of the Charlson comorbidity index
(14,15). Other characteristics, such as teaching status
of the hospital, hospital bed size, insurance status,
and discharge disposition, were also included.
STUDY OUTCOMES. The primary outcome was in-
hospital mortality. Secondary outcomes were
divided as procedural outcomes (which included PCI,
coronary artery bypass grafting [CABG], thrombol-
ysis, use of an intra-aortic balloon pump [IABP],
percutaneous ventricular assist device [pVAD] or
extracorporeal membrane oxygenation [ECMO], right
heart catheterization, and permanent left ventricular
assist device placement) and clinical outcomes
(which included acute kidney injury [AKI], AKI
requiring dialysis, ischemic stroke, major bleeding,
length of stay, and total hospital costs adjusted for
inflation up to July 2018).
STATISTICAL ANALYSIS. Univariate differences in
baseline characteristics between our cohorts were
evaluated using Pearson chi-square tests for cate-
gorical variables and Wilcoxon rank sum tests for
continuous variables. Multivariate linear and logistic
regression was used to compare hospital outcomes
between groups, adjusting for potential confounders,
which included age, Charlson comorbidity index,
hospital bed size, teaching status, and insurance.
Statistical analysis was performed using Stata version
14 (StataCorp, College State, Texas). A p value <0.05
was considered to indicate statistical significance for
all analyses.
RESULTS
We identified a total of 159,339 patients with STEMI
and CS, of whom 57,839 (36.3%) were women. Of
those women, 77.9% were White, 8.6% were Black,
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and 6.8% were Hispanic. Women were older (69.8
years vs. 63.2 years; p < 0.001) and overall had a
higher burden of comorbidities (Table 1). Hyperten-
sion, diabetes mellitus, and obesity were more com-
mon in women, whereas hyperlipidemia, chronic
obstructive lung disease, smoking, and alcohol abuse
were more common in men. Hypertension was most
prevalent in Black women (67.9%), followed by His-
panic women (64.9%). Diabetes mellitus was most
prevalent in Hispanic women (58.2%), followed by
Hispanic men (48.8%), followed by Black women
(46.2%). Women were less likely to have undergone
prior PCI and to have known coronary artery disease
compared with men.
Women were less likely to undergo invasive car-
diac procedures compared with men. These proced-
ures included right heart catheterization;
revascularization with PCI, thrombolysis, or CABG;
TABLE 1 Baseline Characteristics


















Age (yrs) 65.6 72.0 61.7 66.8 62.7 69.5 62.7 71.0 <0.01
Comorbidities
Hypertension 52.9 58.3 59.5 67.9 58.0 64.9 55.3 60.4 <0.01
Diabetes mellitus 27.7 30.6 36.5 46.2 48.8 58.2 38.9 42.9 <0.01
Insulin-dependent diabetes 2.4 3.3 3.8 5.9 3.9 5.9 3.8 6.4 <0.01
Dyslipidemia 43.1 40.4 39.0 40.9 44.8 41.0 45.2 39.9 <0.01
COPD 17.8 19.0 10.9 8.9 10.9 8.1 10.7 8.6 <0.01
End-stage renal disease 2.0 1.8 7.1 9.8 5.9 6.7 3.1 3.5 <0.01
Obesity 10.9 11.9 8.1 17.0 9.8 14.6 6.5 8.7 <0.01
Peripheral vascular disease 10.8 12.7 10.9 13.6 10.2 13.6 8.5 9.0 <0.01
Smoking 38.1 27.8 34.7 23.9 31.2 15.4 31.9 15.8 <0.01
Alcohol abuse 5.6 1.5 6.8 1.3 6.9 1.1 3.9 0.8 <0.01
Drug abuse 2.1 1.2 9.4 3.1 3.2 0.8 1.8 0.8 <0.01
Prior myocardial infarction 8.2 6.4 7.7 7.1 7.3 7.5 7.1 4.9 <0.01
Prior PCI 10.4 7.3 10.8 7.1 9.6 7.2 8.4 6.8 <0.01
Prior CABG 3.8 2.7 2.4 3.0 3.3 3.4 3.7 1.4 <0.01
Prior stroke/TIA 4.4 6.5 7.0 9.6 5.0 7.3 4.8 6.0 <0.01
Known CAD 78.1 70.6 73.1 68.5 77.3 72.6 79.8 72.4 <0.01
Carotid artery disease 1.2 1.2 0.5 0.9 0.8 1.0 0.6 0.3 0.01
Atrial fibrillation 23.6 24.4 13.9 14.8 17.6 19.2 17.8 20.3 <0.01
Anemia 15.4 20.9 20.2 28.1 22.4 27.5 18.9 24.7 <0.01
Charlson comorbidity index
0 18.8 21.3 18.8 20.9 22.5 23.1 22.4 22.9 <0.01
1 26.8 22.9 23.6 16.8 20.6 15.8 24.8 21.0
2 32.1 31.9 27.3 27.6 30.8 27.8 32.0 32.2
$3 22.2 24.0 30.3 34.8 26.2 33.3 20.8 24.0
Other characteristics
Teaching hospital 53.5 50.9 69.7 68.4 51.8 53.7 61.4 58.8 <0.01
Hospital bed size
Small 8.3 9.5 7.8 6.4 7.9 6.7 11.2 13.5 <0.01
Medium 22.3 23.0 21.3 23.6 22.4 21.7 21.0 20.7
Large 69.5 67.6 70.8 70.0 69.7 71.6 67.8 65.8
Median household income
0 to 25th percentile 24.1 25.8 53.3 52.6 38.8 39.2 21.9 20.8 <0.01
26th to 50th percentile 27.1 27.6 20.5 20.5 23.7 22.5 20.4 21.1
51st to 75th percentile 26.0 24.3 14.8 15.6 22.7 22.8 23.4 26.5
76th to 100th percentile 22.8 22.4 11.4 11.4 14.8 15.6 34.3 31.7
Primary payer
Medicare/Medicaid 56.5 74.7 58.5 71.9 55.1 70.1 50.2 69.9 <0.01
Private insurance 32.2 19.5 25.4 19.7 26.1 16.4 34.6 18.3
Self-pay/other 11.3 5.8 16.1 8.4 18.9 13.5 15.2 11.9
Discharge disposition
Home 68.0 58.0 66.5 61.1 71.3 63.1 71.2 59.2 <0.01
Nursing home/facility 22.9 34.8 24.2 30.6 17.2 27.3 17.6 27.6
Transfer to another hospital 8.5 6.9 8.5 8.1 10.5 9.5 10.7 13.0
Values are %.
CABG ¼ coronary artery bypass grafting; CAD ¼ coronary artery disease; COPD ¼ chronic obstructive pulmonary disease; PCI ¼ percutaneous coronary intervention;
TIA ¼ transient ischemic attack.
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and mechanical circulatory support with an IABP, a
pVAD, or ECMO (Table 2). Women underwent PCI less
often compared with men. PCI was performed in
62.9% of White women compared with 67% of White
men. PCI was performed in 59.4% of Black women
compared with 66.4% of Black men. PCI was per-
formed in 58.5% of Hispanic women compared with
66.9% of Hispanic men. Similarly, women had lower
rates of CABG compared with men. Women had lower
rates of right heart catherization and mechanical cir-
culatory support use, including IABPs, pVADs, ECMO,
and durable left ventricular assist devices, compared
with men with STEMI and CS (Central Illustration).
In-hospital mortality was higher in women
compared with men. White women had a mortality
rate of 40.9%, compared with 33.3% for White men.
Black women had a mortality rate of 40%, compared
with 33.6% for Black men. Hispanic women had a
mortality rate of 45.4%, compared with 34.7% for
Hispanic men. We performed multivariate analysis
comparing mortality on the basis of sex and race/
ethnicity combined. After adjusting for age, Charlson
comorbidity index, hospital bed size, hospital teach-
ing status, and insurance using White men as the
reference, women from all races had significantly
higher odds of in-hospital mortality (adjusted odds
ratio [aOR]: 1.11; 95% confidence interval [CI]: 1.06 to
1.16; p < 0.001) (Figure 1). Black and Hispanic men
also had significantly higher odds of in-hospital
mortality compared with White men (Black men:
aOR: 1.18; 95% CI: 1.04 to 1.34; p ¼ 0.011; Hispanic
men: aOR: 1.19; 95% CI: 1.06 to 1.33; p ¼ 0.003)
(Table 3).
The incidence of AKI was generally lower in
women compared with men. We found that Black
men had the highest rates of major bleeding (10.7%)
across all groups (Table 2). We also found that women
generally had higher rates of stroke compared with
men (3.4% for White women compared with 3.1% for
White men, 4.1% for Hispanic women compared with
3.4% for Hispanic men), with the highest rate of
stroke (4.7%) in Black women across all study groups.
Women also had higher rates of palliative care
consultation compared with men, with the highest
rate of palliative care consultation in White women
(9.3%) across all the study groups. After exclusion of
patients who died, female sex was associated with
lower mean cost ($41,005 vs. $48,846) and median
length of stay (5 days vs. 6 days), with White women
having the lowest cost of care ($37,105) and shortest
length of stay (5 days; interquartile range: 2 to
10 days) across all groups (Table 2).
DISCUSSION
In the present analysis, we demonstrate the com-
bined effect of racial, ethnic, and sex differences on
clinical and procedural outcomes in patients with
STEMI and CS. We found that women of all races and
ethnicities and men from racial and ethnic minorities
had higher odds of in-hospital mortality compared
with White men. In particular, Hispanic women had
TABLE 2 Procedural and Clinical Outcomes Stratified by Race, Ethnicity, and Sex in Patients With CS-STEMI
White Black Hispanic Other
p ValueMen Women Men Women Men Women Men Women
Procedural outcomes
Percutaneous coronary intervention 67.0 62.9 66.4 59.4 66.9 58.5 65.4 57.6 <0.001
CABG 15.4 9.7 11.4 10.3 15.5 10.7 16.3 12.1 <0.001
Thrombolysis 2.1 1.9 2.8 2.0 3.1 2.0 2.8 2.7 0.019
IABP 53.3 41.9 51.2 45.4 57.0 44.3 56.2 43.5 <0.001
Percutaneous ventricular assist device 3.3 1.9 4.0 3.2 3.1 2.3 4.7 2.9 <0.001
ECMO 1.0 0.6 1.1 1.0 1.0 0.6 2.0 1.1 <0.001
Right heart catheterization 16.7 15.1 16.5 15.5 19.3 16.1 22.4 17.9 <0.001
Permanent LVAD placement 0.7 0.3 0.6 0.2 0.4 0.4 0.8 0.5 0.018
Clinical outcomes
Mortality 33.3 40.9 33.6 40.0 34.7 45.4 30.4 43.2 <0.001
Major bleeding 8.3 8.4 10.7 9.3 10.4 9.8 8.9 10.2 0.004
AKI 38.3 33.2 44.8 40.7 40.7 39.2 39.0 40.0 <0.001
AKI requiring dialysis 3.2 2.6 4.3 4.1 6.0 4.8 5.4 5.2 <0.001
Stroke 3.1 3.4 4.0 4.7 3.4 4.1 4.3 3.8 0.011
Palliative care consultation 6.6 9.3 6.4 6.8 6.1 6.1 4.7 7.9 <0.001
Length of stay (days) 6 (3–11) 5 (2–10) 6 (3–12) 6 (2–13) 6 (3–11) 5 (2–11) 7 (3–12) 5 (2–10) 0.001
Mean hospital costs ($) 45,599 37,105 46,300 42,414 49,666 41,997 53,819 42,502 <0.001
Values are % or median (interquartile range).
AKI ¼ acute kidney injury; ECMO ¼ extracorporeal membrane oxygenation; IABP ¼ intra-aortic balloon pump; LVAD ¼ left ventricular assist device; CS-STEMI ¼ cardiogenic
shock-ST-segment elevation myocardial infarction; other abbreviations as in Table 1.
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the highest risk for in-hospital mortality. Women
underwent fewer invasive cardiac procedures
compared with men, including reperfusion, right
heart catheterization, and mechanical circulatory
support. Black women had the highest rate of
ischemic stroke, while White women had the highest
rates of palliative care consultation. Overall, there are
considerable disparities in the care of patients with
STEMI and CS.
Numerous studies have demonstrated that women
undergo less revascularization compared with men
(16–24) for acute coronary syndrome. D’Onofrio et al.
(17) analyzed outcomes among 1,465 patients with
STEMI in the VIRGO (Variations in Recovery: Role of
Gender on Outcomes of Young AMI) study and
demonstrated that younger women were less likely to
receive reperfusion therapy and more likely to have
reperfusion delays compared with men. This is
despite evidence that women derive similar benefits
from revascularization (18). Barthélémy et al. (16)
analyzed outcomes among 775 consecutive patients
with STEMI and found that 23.5% of women under-
went PCI. Women who underwent PCI had similar 1-
year outcomes compared with men, despite a higher
risk profile at baseline, including more CS, illustrating
further that women have similar benefit from PCI
compared with men.
The observation that women undergo less revas-
cularization compared with men could be attributed
to having less severe obstructive coronary artery
disease and a higher prevalence of other etiologies of
myocardial infarction, including takotsubo cardio-
myopathy, microvascular dysfunction, coronary
vasospasm, and spontaneous coronary artery dissec-
tion, among other etiologies described under a
broader terminology increasingly used by the car-
diovascular community, myocardial infarction with
nonobstructive coronary arteries (19,20). However,
this does not explain why women underwent less
right heart catheterization and mechanical circulatory
support in the setting of shock compared with men,
as seen in our analysis. Studies have shown that right
heart catheterization can facilitate decision making
and was associated with decreased mortality in pa-
tients with acute myocardial infarction complicated
by CS who received pVADs (21,22). In addition, Joseph
et al. (23) demonstrated in their analysis of patients
with acute myocardial infarction complicated by CS
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Racial, ethnic, and sex disparities were seen in the rates of in-hospital mortality, revascularization, mechanical circulatory support, and right heart catheterization in
patient with ST-segment elevation myocardial infarction and cardiogenic shock.
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from the cVAD registry that early initiation of hemo-
dynamic support prior to PCI with the Impella 2.5 was
associated with a greater survival benefit to hospital
discharge in women compared with men, despite a
higher rate of revascularization failure for women.
Despite continued medical advancements, signifi-
cant disparities exist in the cardiac care of Black pa-
tients, from prevention to invasive treatments and
outcomes (24,25). Black patients tend to have longer
delays in receiving medications, revascularization,
and surgical treatments in acute coronary syndrome,
including longer door-to-balloon times (25). These
disparities persist even in patients with STEMI, as
Anstey et al. (25) demonstrated in their analysis of the
ACTION-Registry (Acute Coronary Treatment and
Intervention Outcomes Network Registry–Get With
the Guidelines), in which Black patients, both men
and women, presenting with STEMI were less likely
to undergo revascularization. Studies have shown
that Black patients presenting with acute myocardial
infarction are more likely to be younger, to have
Medicaid insurance or no insurance, to have lower
income, and to have more comorbidities compared
with Whites (24). Consistent with prior data, our
analysis confirms that Black patients with STEMI and
CS tended to be younger and to have lower incomes.
In our analysis, Black patients also underwent CABG
less often and had higher rates of AKI, AKI requiring
dialysis, major bleeding, and stroke compared with
White patients. Black men had the highest rate of
major bleeding across all groups in our cohort.
Moreover, after adjusting for age, insurance, Charlson
comorbidity index, hospital bed size, and teaching
status, Black men had significantly higher odds of in-
hospital mortality compared with White men.
Similar disparities exist in health care for Hispanic
patients (24,26). Previous studies have demonstrated
that Hispanic patients with myocardial infarction
were younger, were more likely to be uninsured, and
had a higher prevalence of diabetes mellitus (24).
Hispanic patients experienced longer delays in
receiving medication, revascularization, or surgical
treatment for myocardial infarction compared with
White patients, including longer door-to-balloon
times (24). Similarly, Mochari-Greenberger et al. (26)
found increased mortality and rehospitalizations
among Black and Hispanic patients with coronary
artery disease compared with White or Asian patients
at 1 year. In our analysis, we confirm that Hispanic
patients with STEMI and CS were younger, had a
higher prevalence of diabetes mellitus, and were
more likely to have no insurance. Similar to Black
patients, Hispanic patients had higher rates of AKI,
AKI requiring dialysis, and major bleeding. Impor-
tantly, we present data that Hispanic women had the
highest in-hospital mortality of all patients with
STEMI and CS, even after adjusting for age, insur-
ance, Charlson comorbidity index, hospital bed size,
and hospital teaching status.
The causes of racial, ethnic, and sex disparities in
health care are complex and a result of sophisticated
interactions among the health care system,
FIGURE 1 Forest Plot Figure Illustrating Mortality by Sex and Race
Odds ratios for in-hospital mortality were higher for all women as well as Black and
Hispanic patients compared with White men. Odds ratios were adjusted for age, Charlson
comorbidity index, hospital bed size, hospital teaching status, and insurance using White
men as reference.
TABLE 3 Adjusted Odds Ratios for In-Hospital Mortality for Each
Subgroup Compared With White Men, After Adjusting for Age,
Charlson Comorbidity Index, Hospital Bed Size, and Hospital
Teaching Status
aOR 95% CI p Value
White women 1.09 1.03–1.15 0.001
Black men 1.18 1.04–1.34 0.011
Black women 1.29 1.12–1.49 <0.001
Hispanic men 1.19 1.06–1.33 0.003
Hispanic women 1.46 1.26–1.70 <0.001
Other men 0.97 0.87–1.09 0.636
Other women 1.26 1.07–1.48 0.004
Odds ratios were adjusted for age, Charlson comorbidity index, hospital bed size,
and hospital teaching status.
aOR ¼ adjusted odds ratio; CI ¼ confidence interval.
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socioeconomic status, cultural background, and per-
sonal preferences (24). As such, effective solutions
need to account for all of these factors to achieve
consistent equity and outcomes. Studies have shown
that implementing universal protocols and rigorous
guideline adherence have helped diminish treatment
disparities, including delays in treatment, in diverse
patients with myocardial infarction (27,28). Huded
et al. (27) demonstrated that STEMI protocols led to
resolution of sex differences in STEMI care, including
the use of guideline-directed medical therapy, door-
to-balloon times, and in-hospital adverse events.
Moreover, these protocols also led to a decreased,
although persistent, sex discrepancy in 30-day mor-
tality, highlighting that more work is needed to
address all contributing factors in this critically ill
patient population. In another study of more than 2
million patients with acute myocardial infarctions,
the racial and ethnic disparity in quality measures
diminished significantly after strict guideline adher-
ence for both Black and Hispanic patients compared
with White patients (28). It is important to emphasize
here that the poor outcomes observed in women and
minorities should not preclude them from receiving
lifesaving therapies. In fact, it should urge us as
physicians to lead the health care system to improve
outcomes in less advantaged patients and overcome
barriers such as delays in treatment and differences in
hospital practice. The use of shock protocols has been
associated with improved outcomes in patients with
STEMI and CS (3,4). We postulate that implementing
these protocols will similarly lead to reductions in the
racial, ethnic, and sex disparities demonstrated in
this analysis. As we move forward in designing and
conducting randomized control trials in STEMI and
CS, we must enroll diverse patient populations and
continue the call to action of increasing diversity in
trial leadership and the greater cardiovascular
community.
STUDY LIMITATIONS. Data collected from the NIS use
International Classification of Diseases codes, so
diagnosis coding could be inaccurate and variable
according to providers’ preferences and variability in
documentation. The definition of CS is self-reported
using International Classification of Diseases-9th
Revision diagnostic code, and no hemodynamic data
were available to confirm the diagnosis or define the
stage of CS. Similarly, there could be unmeasured and
unknown confounding factors such as differences in
management in community and tertiary care centers,
delays in pre-hospital care and admission, and vari-
ability in treatments that could contribute to worse
outcomes within the subgroups. Laboratory and
angiographic findings that contribute to decision
making in patients with STEMI and CS are lacking;
these include TIMI (Thrombolysis In Myocardial
Infarction) flow and infarct-related artery among
other variables. In addition, there is no documenta-
tion of the pre-hospitalization delays, first medical
contact to revascularization, and timing of mechani-
cal circulatory support, which could influ-
ence outcomes.
CONCLUSIONS
Our analysis demonstrates the presence of significant
sex, racial, and ethnic disparities in the care of pa-
tients with STEMI and CS. This heterogenous care
may result from implicit bias and warrants further
study in an effort to optimize care for all patients,
irrespective of their race, ethnicity, or sex. The use of
shock protocols may be an initial step to help mini-
mize these disparities.
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PERSPECTIVES
WHAT IS KNOWN? Several studies have shown racial and sex
disparities in the care of patients with myocardial infarction. Our
study looks at the combined racial, sex, and ethnic disparities in a
specific population, patients with STEMI and CS.
WHAT IS NEW? To our knowledge, very little is known
regarding the disparities in this very sick population. In our
analysis, we demonstrate significant disparities on the basis of
race, ethnicity, and sex in the care and outcomes of patients with
STEMI and CS.
WHAT IS NEXT? We propose possible solutions and highlight
the need for further studies to address these issues and decrease
the gap, in order to provide care for all patients, irrespective of
their race, sex, or ethnicity.
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